ArticleFrontiers in pharmacology2022

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Rui Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.